Miguel Sogbe

MD,PhD

Liver Unit-Clínica Universidad de Navarra

[Miguel Sogbe @msogbe93]

Reencuentro muy especial con mis amigos de la Liver-vida. @AstridRuizMarg @YucaSpice

[Clínica Universidad de Navarra @ClinicaNavarra]

Según la Dra. Madeleine di Frisco, los pacientes con cáncer de pulmón avanzado que además presentan #EPOC y enfisema muestran una mejor respuesta a ciertos tratamientos de inmunoterapia. Lo cuenta en @diariomedico https://t.co/8LPZdjdLKZ

[PhD_Genie @PhD_Genie]

Paper accepted without corrections

[Northwestern Medicine Transplant @NM_Transplant]

Transplant Hepatologist Andres Duarte-Rojo, MD, and Susanna Miranda, DNP, APRN, are leading our efforts to help strengthen patients preparing for a liver transplant, helping improve the long-term outcomes. Read about their approach. https://t.co/f5e2JdFuKs

[Northwestern Medicine Digestive Health Institute @NMGastro]

Andres Duarte-Rojo (@YucaSpice), MD, professor of Medicine and Surgery at Northwestern Medicine, and Susanna Miranda, DNP, APRN, lead a multidisciplinary liver transplant rehabilitation team that aims to reduce frailty and enhance survival for patients preparing for liver transplantation.

See how this program is improving post-transplant outcomes: https://t.co/L8ZqwGw7UO

[Elliot Tapper @ebtapper]

What if Ferritin applied for a job?

[AJG - The American Journal of Gastroenterology @AmJGastro]

Psychomotor Speed From Minimal Hepatic Encephalopathy Testing Is Associated With Physical Frailty in Patients With Advanced Chronic Liver Disease
Sogbe, et al.

📕 https://t.co/MjNunNckE4

@msogbe93 @YucaSpice @MLongMD @JasmohanBajaj

[Miguel Sogbe @msogbe93]

@AmJGastro @YucaSpice @MLongMD @JasmohanBajaj @ClinicaNavarra @NMGastro @NM_Transplant

[Northwestern Medicine Transplant @NM_Transplant]

We’re excited to announce the appointment of Andres Duarte, MD, PhD, as the new section chief of Hepatology and director of Liver Transplant at Northwestern Medicine. Read the full story here: https://t.co/bDz2DEkcdd

[Sagnik Biswas @JustSagnik]

Plasma exchange in ACLF-
😎 Improved short term survival
❗️Tolerance was an issue
🤔90-day survival was similar
🟥Infections are a cause for concern

Only a bridge to transplant?
@aiims_newdelhi @drshalimar @AASLDtweets @BavenoCoop @EASLnews @INASL_Liver @ShekharSwa9790

[EASLnews @EASLnews]

🗞️News from A-TANGO!

We celebrate a new consortium publication by Cornelius Engelmann et al. (2026) that introduces the A-TANGO organ failure (OF) score, a refined tool for diagnosing acute-on-chronic liver failure (ACLF) in patients with cirrhosis and acute decompensation.

Developed using data from 3,896 patients in Europe and Latin America and validated in large cohorts from India and China, the score updates thresholds for organ dysfunction and adds a new ACLF grade 4 to better capture severely ill patients. Compared with the widely used CLIF-C OF score, A-TANGO improves detection of ACLF (24% to 36%) while maintaining strong prediction of 28- and 90-day mortality. The study also introduces two related prognostic models.

Together, these tools provide a more accurate framework for risk stratification, treatment evaluation, and the design of clinical trials in ACLF.

👉Read the publication here: https://t.co/j3InnWniaZ

[Astrid Ruiz Margáin @AstridRuizMarg]

Increíbles pláticas y discusión sobre trasplante hepático de donante vivo, su aplicación clínica, indicaciones, ventajas, además de aspectos técnicos e innovación en técnicas quirúrgicas de @NMGastro

Gracias @NayelliCointa @YucaSpice
#JCCaicedo #DanielBorja

@incmnszmx

[Maria Varela @Maria_Var_Cal]

@HUCA_Asturias multidisciplinary liver cancer team contribution to European Liver Cancer Summit @EASLnews
#biomarkers
#TARE_Y90

[Miguel Sogbe @msogbe93]

✨ A true joy working along with such an outstanding team on this project. @AstridRuizMarg @INCMNSZ_DirInv @brittybb @YucaSpice @NM_Transplant @ClinicaNavarra @GrupoJovenAEEH @AEEHLiver
Full paper here 👇
https://t.co/rryiKUgYO5

[Miguel Sogbe @msogbe93]

🧵 THREAD | Free testosterone and survival in advanced liver disease
📢 Here’s a new paper from our group! Here are the highlights 👇

[Miguel Sogbe @msogbe93]

🔟
📌 Take-home message:
👉 Free testosterone outperforms total testosterone as a prognostic marker in ACLD.
👉 Measuring FT may help identify high-risk patients and guide prehabilitation and future therapeutic strategies.